Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Ganglioneuroblastoma
100%
Pediatrics
79%
Tumor
43%
Soft Tissue Sarcoma
42%
Rhabdomyosarcoma
39%
Neoplasm
32%
Adolescence
26%
Chemotherapy
23%
Diseases
22%
Childhood Cancer
22%
Radiation Therapy
20%
Overall Survival
20%
Event Free Survival
20%
Malignant Neoplasm
13%
Pediatrics Patient
12%
Metastatic Carcinoma
12%
Minimal Residual Disease
11%
Messenger RNA
10%
Synovial Sarcoma
10%
Connective Tissue Cancer
9%
Clinical Trial
9%
Genetics
8%
(3 Iodobenzyl)guanidine
8%
Local Therapy
7%
Pediatric Cancer
7%
Lymph Node
7%
Adverse Event
7%
Wilms' Tumor
7%
Median Follow Up
7%
Solid Malignant Neoplasm
6%
Immunotherapy
6%
Magnetic Resonance Imaging
6%
Plasma Cell Granuloma
6%
Organoid
6%
Fibrosarcoma
5%
Malignant Peripheral Nerve Sheath Tumor
5%
Iodine 131
5%
Stem Cell
5%
Biological Marker
5%
Scintigraphy
5%
Cancer
5%
Keyphrases
Neuroblastoma
62%
Pediatric Soft Tissue Sarcoma
24%
High-risk Neuroblastoma
23%
Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
18%
Event-free Survival
15%
Tumor
13%
Overall Survival
13%
Radiotherapy
12%
Chemotherapy
10%
Working Diagnosis
10%
Rhabdomyosarcoma
10%
Pediatric
9%
Synovial Sarcoma
8%
Minimal Residual Disease
8%
95% Confidence Interval
7%
Pediatric Patients
7%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
6%
Preadolescent children
6%
Pediatric Adrenocortical Tumors
6%
Pediatric Tumors
6%
Pediatric Oncology
6%
MYCN Amplification
5%
Netherlands
5%
Clinical Trials
5%
Nuclear Imaging
5%